.png)
.png)
Latest news from BIA
UK Confirms its Leadership Position in Advanced Therapies
Cell and gene therapies and tissue-engineered products have the potential to offer a durable, life-changing effect, possibly with single administration New report from Alliance for Regenerative Medicine and UK BioIndustry Association highlights progress in financing and clinical trials 24% of Europe’s ATMP developers headquartered in the UK
BIA warns there is little time to avoid disruption as government announces ‘no-deal’ Brexit planning
Steve Bates OBE, CEO of the BIA responds to the Written Ministerial Statement on EU Exit preparedness published by the Government today.
UK Biotech forges links with new global investors
The UK BioIndustry Association (BIA) is hosting the key movers from the Hong Kong stock exchange in London this week as part of a strategic push to enable global investors to get to know the opportunities in UK biotech.
World leading antibody scientist Dr Jane Osbourn awarded OBE in Queen’s Honours
Dr Jane Osbourn, Vice-President of Research and Development at AstraZeneca and Chair of the UK BioIndustry Association (BIA) has been made an Officer of the Order of the British Empire (OBE) in the Queen’s birthday honours list.
PhoreMost appoints Dr Lorenz Mayr as Non-Executive Director
Board appointment will help guide target identification and drug discovery
Dr. Philip Beer joins CCG.ai
Dr. Philip Beer joins Cambridge Cancer Genomics as Head of Translational Medicine
Invest Newcastle show off the region’s innovative life science sector to Cuban visitors
Invest Newcastle has welcomed a senior Cuban life science business delegation to the region for a two-day visit. They used this opportunity to show off the city’s life science strengths and world-leading universities.
Arecor Signs A New Formulation Evaluation Agreement With An Existing Partner, A Major Global Pharmaceutical Company
Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company.
CEO Update | Monday 22 July
In a week that will see a change of UK Prime Minister, I was delighted to be able to provide a positive and optimistic boost for the UK economy in launching a joint report with the Alliance of Regenerative Medicines, titled Leading Innovation: The UK’s ATMP landscape, which shows the UK’s globally leading position in advanced therapies, which includes the development of potentially transformative cell and gene therapies.
BIA Parliament Day 2019
This year marked our 19th Annual Parliament Day event, which brings BIA members from across the sector to meet with parliamentarians, senior NHS leaders and civil servants from the Department for Business, Energy and Industrial Strategy and HM Treasury. As our flagship influencing event, Parliament Day facilitates important interactions between BIA members and policymakers across Westminster and Whitehall.
CEO Update | Monday 15 July 2019
Last week we held our 19th annual BIA Parliament Day, bringing over 30 biotech sector leaders to Westminster to meet MPs, civil servants and NHS senior leadership. It was a great opportunity to highlight the value of the sector to key senior stakeholders and also for our members to learn more about what is going on in the machinery of government. Thank you to all members who helped make it such a success.
Access to medicines in Parliament
Today, as the BIA brings senior representatives from across the UK’s life sciences sector to meet with parliamentarians and civil servants for our annual Parliament Day, we thought we’d take a look at another key way we engage with Parliament – the All Party-Parliamentary Group (APPG) for Life Sciences.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector, BIA update: January - April 2018
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from January to April 2018.
Biotech Financing Update: December 2017 to February 2018
The BIA/Informa Biotech Financing Update: December 2017-February 2018 released today shows that venture capital financing and follow on financing on the public markets are off to a solid start in 2018.
Pipeline Progressing: The UK's Global Bioscience Cluster in 2017
A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.
BIA Best practice guide for communicating R&D
Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.
